Cargando…

Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR)

Atherosclerosis is responsible for the majority of heart attacks and is characterized by several modifications of the arterial wall including an inflammatory reaction. The silent course of atherosclerosis has made it necessary to develop predictors of disease complications before symptomatic lesions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anzola, Luz Kelly, Rivera, Jose Nelson, Ramirez, Juan Carlos, Signore, Alberto, Mut, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658082/ https://www.ncbi.nlm.nih.gov/pubmed/34884218 http://dx.doi.org/10.3390/jcm10235515

Ejemplares similares

mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015)

Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
por: Harda, Kristof, et al.
Publicado: (2020)

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?
por: Dalm, Simone U., et al.
Publicado: (2017)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Yu, Benxia, et al.
Publicado: (2017)

Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis
por: War, Sajad A, et al.
Publicado: (2012)

Retracted: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Song, Hao, et al.
Publicado: (2018)

Sjögren Syndrome: New Insights in the Pathogenesis and Role of Nuclear Medicine
por: Kelly, Anzola Luz, et al.
Publicado: (2022)

Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Somatostatin receptors (SSTR1-5) on inhibitory interneurons in the barrel cortex
por: Lukomska, Agnieszka, et al.
Publicado: (2019)

Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
por: Costa, Ricardo, et al.
Publicado: (2013)

Beta cell primary cilia mediate somatostatin responsiveness via SSTR3
por: Adamson, Samantha E., et al.
Publicado: (2023)

Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells
por: Modarai, Shirin R., et al.
Publicado: (2016)

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
por: Eychenne, Romain, et al.
Publicado: (2020)

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
por: Ambrosini, Valentina, et al.
Publicado: (2022)

FRI623 Beta Cell Primary Cilia Mediate Somatostatin Responsiveness Via SSTR3
por: Elizabeth Adamson, Samantha, et al.
Publicado: (2023)

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
por: Mizutani, Gou, et al.
Publicado: (2012)

Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
por: Fani, Melpomeni, et al.
Publicado: (2022)

Effects of somatostatin analogs on uptake of radiolabeled somatostatin analogs on imaging: a systematic review and meta-analysis
por: Wang, Rang, et al.
Publicado: (2023)

Molecular-Level Understanding of the Somatostatin Receptor 1 (SSTR1)–Ligand Binding: A Structural Biology Study Based on Computational Methods
por: Nagarajan, Santhosh Kumar, et al.
Publicado: (2020)

Noninvasive diagnosis of vulnerable coronary plaque
por: Pozo, Eduardo, et al.
Publicado: (2016)

A Cyanine‐Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation
por: Heing‐Becker, Isabelle, et al.
Publicado: (2021)

Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
por: Johnson, Felix, et al.
Publicado: (2023)

A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs
por: Crespo-Jara, Aurora, et al.
Publicado: (2016)

SPECT/CT with radiolabeled somatostatin analogues in the evaluation of systemic granulomatous infections
por: Monteiro, Paulo Henrique Silva, et al.
Publicado: (2017)

Identification of Somatostatin Receptor Subtype 1 (SSTR1) Gene Polymorphism and Their Association with Growth Traits in Hulun Buir Sheep
por: Li, Xue, et al.
Publicado: (2021)

Synthesis and preliminary evaluation of octreotate conjugates of bioactive synthetic amatoxins for targeting somatostatin receptor (sstr2) expressing cells
por: Pryyma, Alla, et al.
Publicado: (2021)

Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?
por: Cuccurullo, Vincenzo, et al.
Publicado: (2017)

Molecular simulations of SSTR2 dynamics and interaction with ligands
por: Gervasoni, Silvia, et al.
Publicado: (2023)

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
por: Mehta, Shreya, et al.
Publicado: (2015)

The effect of strength and endurance training on SSTR2 and SSTR5 in patients with colorectal cancer
por: Zanjani, Farhad Safari, et al.
Publicado: (2019)

Targeting vulnerable atherosclerotic plaque via PET-tracers aiming at cell-surface overexpression of somatostatin receptors
por: Z. Papadakis, Georgios, et al.
Publicado: (2020)

Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)
por: Varani, Michela, et al.
Publicado: (2022)

Methods for Radiolabelling Nanoparticles: PET Use (Part 2)
por: Bentivoglio, Valeria, et al.
Publicado: (2022)

Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use
por: Bentivoglio, Valeria, et al.
Publicado: (2023)

Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience
por: Filice, A., et al.
Publicado: (2012)

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
por: Bison, Sander M., et al.
Publicado: (2014)

Metastatic Malignant Paraganglioma Presenting as a Neck Mass Treated with Radiolabeled Somatostatin Analog
por: Jehangir, Waqas, et al.
Publicado: (2021)

Imaging Bacteria with Radiolabelled Probes: Is It Feasible?
por: Signore, Alberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jcd0qg5pa69vmcnog2l7j8tim8